What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His main research concerns Internal medicine, Endocrinology, Heart failure, Cardiology and Cell biology.
Endothelial dysfunction, Mineralocorticoid receptor, Muscle hypertrophy, Aldosterone and Oxidative stress are the subjects of his Endocrinology studies.
His Endothelial dysfunction research includes elements of Glucose-6-phosphate dehydrogenase activity, CREB, CAMP-Responsive Element Modulator, Nitric oxide and Hyperaldosteronism.
His Heart failure study integrates concerns from other disciplines, such as Heart disease, Macrophage and Glucose uptake.
His Cardiology research incorporates themes from Tissue homeostasis, Diastole and Monocyte.
His work carried out in the field of Cell biology brings together such families of science as Molecular biology, Cellular differentiation and Cell growth.
His most cited work include:
- Telomere dysfunction induces metabolic and mitochondrial compromise (845 citations)
- Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure (747 citations)
- CD31− but Not CD31+ Cardiac Side Population Cells Exhibit Functional Cardiomyogenic Differentiation (468 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Endocrinology, Heart failure, Cardiology and Cell biology.
In his papers, Ronglih Liao integrates diverse fields, such as Internal medicine and Pressure overload.
Ronglih Liao combines subjects such as Biochemistry, Signal transduction and Calcium with his study of Endocrinology.
The concepts of his Heart failure study are interwoven with issues in Heart disease and Disease.
His Cell biology research includes elements of Immunology, Cell, Programmed cell death and Cellular differentiation.
His work deals with themes such as Cancer research and Amyloidosis, which intersect with Cardiomyopathy.
He most often published in these fields:
- Internal medicine (60.84%)
- Endocrinology (35.74%)
- Heart failure (28.90%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (60.84%)
- Cardiology (26.62%)
- Heart failure (28.90%)
In recent papers he was focusing on the following fields of study:
Ronglih Liao mainly focuses on Internal medicine, Cardiology, Heart failure, Amyloidosis and Cardiac amyloidosis.
Ronglih Liao performs multidisciplinary study in the fields of Internal medicine and Context via his papers.
His work on Cardiac fibrosis and Muscle hypertrophy as part of general Cardiology research is frequently linked to Pressure overload, bridging the gap between disciplines.
The various areas that Ronglih Liao examines in his Heart failure study include Epidemiology, Dementia, Disease, Induced pluripotent stem cell and Diastole.
His Amyloidosis research is multidisciplinary, incorporating perspectives in Cardiomyopathy and AL amyloidosis, Amyloid.
The Cardiac amyloidosis study combines topics in areas such as Gastroenterology, Nephrotic syndrome and Cholesterol.
Between 2015 and 2021, his most popular works were:
- AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. (198 citations)
- Guidelines for experimental models of myocardial ischemia and infarction. (192 citations)
- Cardiac macrophages promote diastolic dysfunction. (126 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Ronglih Liao spends much of his time researching Heart failure, Cardiology, Internal medicine, Amyloidosis and Cardiac amyloidosis.
His Heart failure study incorporates themes from Diabetes mellitus, Combination therapy, Bioinformatics and Diastole.
His research is interdisciplinary, bridging the disciplines of Macrophage and Internal medicine.
When carried out as part of a general Amyloidosis research project, his work on Amyloid cardiomyopathy is frequently linked to work in Population, therefore connecting diverse disciplines of study.
His Amyloid research is multidisciplinary, incorporating elements of Cardiomyopathy, Transthyretin and Multiple myeloma.
His AL amyloidosis study combines topics from a wide range of disciplines, such as Cardiac function curve, Positron emission tomography and Interquartile range.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
